TYK Medicines, Inc. Class H (2410) Stock Statistics & Valuation Metrics

TYK Medicines, Inc. Class H has a market cap or net worth of HK$6.25B. The enterprise value is HK$4.46B.

TYK Medicines, Inc. Class H has 366,227,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

TYK Medicines, Inc. Class H’s return on equity (ROE) is -0.82 and return on invested capital (ROIC) is -39.75%.

The current PE Ratio of TYK Medicines, Inc. Class H is -38.64. TYK Medicines, Inc. Class H’s PEG ratio is -0.53.

In the last 12 months, TYK Medicines, Inc. Class H had revenue of 107.00K and earned -386.95M in profits. Earnings per share was -1.24.

In the last 12 months, operating cash flow was -136.28M and capital expenditures -18.13M, giving a free cash flow of -154.55M billion.

TYK Medicines, Inc. Class H pays an annual dividend of ―, resulting in a dividend yield of ―

TYK Medicines, Inc. Class H upcoming earnings date is Mar 27, 2025, TBA Not Confirmed.

TYK Medicines, Inc. Class H as a current ratio of 1.97, with Debt / Equity ratio of -4.72%

In the past 12 months, TYK Medicines, Inc. Class H has paid 0.00 in taxes.

TYK Medicines, Inc. Class H EV to EBITDA ratio is -39.19, with an EV/FCF ratio of -38.47.

TYK Medicines, Inc. Class H has HK$158.31M in cash and marketable securities with ¥120.72M in debt, giving a net cash position of -HK$37.59M billion.

Gross margin is 0.00%, with operating margin of -296072.90%, and net profit margin of -361640.19%.

The average price target for TYK Medicines, Inc. Class H is HK$31.60, which is 11.43% higher than the current price. The consensus rating is Moderate Buy